PLK1 and non-small cell lung carcinoma: In conclusion, we demonstrated that Plk1 inhibition leads to apoptosis in mesenchymal NSCLC owing to direct effects on Plk1, as well as parallel vimentin and β1‐integrin–mediated, ligand‐independent inhibition of cMet.